Davis Polk advised the sole book-running manager on an SEC-registered offering by Celgene Corporation of $500 million aggregate principal amount of 2.250% senior notes due 2021. …
Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…
Davis Polk advised Delek Drilling LP, as the selling shareholder, and Tamar Petroleum Limited, as the issuer, on Tamar Petroleum’s international offering of 2,660,000 of its ordinary shares…
Davis Polk advised Calyxt, Inc. in connection with its initial public offering of 8,050,000 shares of its common stock, including 1,050,000 shares of common stock sold pursuant to the full…
Davis Polk advised IHS Markit Ltd. in connection with its Rule 144A/Regulation S offering of an additional $300 million aggregate principal amount of its 4.75% senior notes due 2025. …
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Davis Polk is advising the Conflicts Committee of the board of directors of Pattern Energy Group Inc. in connection with a series of strategic initiatives to increase Pattern Energy’s long…
Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $2.75 billion aggregate principal amount of senior notes in four series, consisting of $300 million…
Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $200 million SEC-registered follow-on offering of 50,000,000 shares of common…